Christian Code


Christian Code has held scientific positions in both industry and academia with an overall focus in biomedicine. His work in both academia and industry has focused on lipids (formulating particles, instruments to measure them) and proteins (characterizing, understanding their interaction). Christian Code currently has a three year Industrial Post-doc position in collaboration with AAK A/S and two Danish universities (SDU & KU) to formulate microparticles for delivery to the ileal brake in the gut to induce satiety. Prior to this he worked at SDU under Prof. David Needham in the center for Single Particle Science and Engineering to look at drugs that can target the lysosome. He further explored protein chemistry at the University of Copenhagen, department of pharmacy, where he worked on characterizing a therapeutic glycoprotein using hydrogen deuterium exchange mass spectrometry.
Christian obtained his Masters at the University of Helsinki as a Marie Curie fellow and continued to Aalto University with Prof. Paavo Kinnunen to obtain a PhD. In his PhD he specialised and published several peer reviewed articles on protein-lipid interactions using biophysical tools. He has a solid background in biochemistry prior to completing his PhD. Christian started along this route as an associate at Inex Pharmaceuticals, a biotechnology company which produced liposomal cancer drugs in Vancouver, Canada. Here he completed projects for two lead drugs from clinical to market.

Professional Experience

  • 2016-present: Postdoc Scientist, AAK in collaboration with SDU & KU

  • 2015-2016: (1 year) Postdoc-Scientist, Department of Physics, Chemistry and Pharmacy, University of Southern Denmark, Odense, DK. Supervisor: Prof. David Needham

  • 2014: (1.5 years) Core Member REBBLS, Copenhagen, DK

  • 2014-2015: (1.5 years) Visiting Scientist, Department of Pharmacy, University of Copenhagen, Copenhagen, DK. Supervisor: Prof. Kasper Rand

  • 2013: Graduated with PhD in Biophysics, Biomedical Engineering and Computational Science (BECS), Aalto University, Espoo, FI.
    PhD Thesis Title: PLA2 Interfacial Activation on Lipid Interfaces Promoting Amyloid Fibril Formation.
    Academic Supervisor: Prof. Paavo Kinnunen

  • 2009-2013: Kibron Inc., Sales Associate Helsinki, FI

  • 2010-2013: PhD Candidate, Department of Biomedical Engineering and Computational Science, Aalto University, Helsinki, FI

  • 2010: Graduated with a Master of Science in Biochemistry from University of Helsinki, FI
    Master’s Thesis Title: Sterols Probing the Universality of Membranes.

  • 2005-2010: Helsinki Biomembrane and Biophysics Group, Institute of Biomedicine University of Helsinki, FI

  • 2008: (1 month) Visiting PhD Student, Institute of Biomembranes, Membrane Biochemistry and Biophysics, University of Utrecht, NL

  • 2008-2010: MSc Department of Biological and Environmental Sciences University of Helsinki, Helsinki, FI

  • 2005-2008: Marie Curie Early Stage Training Fellow, Institute of Biomedicine, University of Helsinki, Helsinki, FI

  • 2005: (5 months) Inovatech, Process Associate, Abbotsford, CA

  • 2003-2004: Inex Pharmaceuticals, Research Associate Process Development, Burnaby, CA

  • 2003-2004: Department of Molecular Biology and Biochemistry/Physics, Simon Fraser University, CA

  • 2003: Graduated with Bachelor of Science, Molecular Biology & Biochemistry, Simon Fraser University, CA Academic
    Supervisors for research study: Profs. Jenifer Thewalt & Martin Zuckermann

  • 2002: (8 months) Inex Pharmaceuticals, Research Associate in Process Development (Coop Student), Burnaby, CA

  • 2001: (4 months) Chevron Refinery Laboratory, Analytical Technician (Coop Student), Burnaby, CA

  • 2000: (4 months) Chevron Refinery Laboratory, Analytical Technician (Coop Student), Burnaby, CA

  • 1997-2003: Bachelor Candidate with Coop, Department of Molecular Biology and Biochemistry, Simon Fraser University, CA


  1. Qiu Danwen, C. Code, C. Quan, BJ, Gong, J. Arndt, B. Pepinsky, K. D. Rand, and D. Houde Investigating the Role of Artemin Glycosylation Pharma. Res. (2016) In Press.

  2. Christian Code PLA2 Interfacial Activation on Lipid Interfaces Promoting Fibril Formation (2013) ISBN9789526053813

  3. Mahalka A., C. Code, Rezai B, Kirkegaard, Jensen T, Jäättelä M and Kinnunen PKJ. BBA Biochim Biophys Acta. 1808, (10): 2569–2572. Activation of Phospholipase A2 by HSP70 in vitro.

  4. Christian Code, Mahalka A., Bry K., Kinnunen PKJ. (2010). Activation of phospholipase A2 by 1palmitoyl2(9'oxononanoyl) snglycero3phosphocholinein vitro. Biotic Biopsy Acta. 1798(8):1593600.

  5. Christian Code, Domanov Y, Killian JA, Kinnunen PKJ. (2009). Activation of Phospholipase A2 by Temporin B: Formation of Antimicrobial PeptideEnzyme Amyloid type Cofibrils. Biochim Biophy Acta. 788(5):106472.

  6. Code C, Domanov Y, Jutila A, Kinnunen PKJ. (2008). Amyloid type Fiber Formation in Control of Enzyme Action: Interfacial Activation of Phospholipase A2. Biophys J. 95(1), 215224.

  7. Hsueh YW, Chen MT, Patty PJ, Code C, Cheng J, Frisken BJ, Zuckermann M, Thewalt J. (2007) Ergosterol in POPC membranes: physical properties and comparison with structurally similar sterols. Biophys J. 92(5):160615.